Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Ischemia, Brain | 16 | 2015 | 55 | 1.860 |
Why?
|
| Cerebral Palsy | 13 | 2015 | 96 | 1.560 |
Why?
|
| Disease Models, Animal | 14 | 2021 | 2494 | 0.920 |
Why?
|
| Rabbits | 20 | 2015 | 618 | 0.720 |
Why?
|
| Muscle Hypertonia | 7 | 2014 | 17 | 0.620 |
Why?
|
| Pulmonary Surfactants | 3 | 2024 | 22 | 0.600 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 2020 | 46 | 0.590 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2024 | 57 | 0.580 |
Why?
|
| Fetal Hypoxia | 4 | 2014 | 14 | 0.530 |
Why?
|
| Gestational Age | 7 | 2019 | 333 | 0.490 |
Why?
|
| Movement Disorders | 3 | 2014 | 43 | 0.490 |
Why?
|
| Nitric Oxide Synthase Type I | 6 | 2012 | 22 | 0.440 |
Why?
|
| Placental Insufficiency | 1 | 2012 | 4 | 0.380 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2021 | 47 | 0.370 |
Why?
|
| Animals, Newborn | 13 | 2015 | 522 | 0.360 |
Why?
|
| Pregnancy | 19 | 2019 | 3147 | 0.360 |
Why?
|
| Infant, Premature | 4 | 2023 | 297 | 0.360 |
Why?
|
| Abortion, Spontaneous | 1 | 2012 | 73 | 0.350 |
Why?
|
| Fetus | 7 | 2013 | 236 | 0.320 |
Why?
|
| Infant, Newborn | 13 | 2024 | 2479 | 0.290 |
Why?
|
| Indomethacin | 2 | 2019 | 58 | 0.290 |
Why?
|
| Ibuprofen | 2 | 2019 | 33 | 0.290 |
Why?
|
| Acetaminophen | 2 | 2019 | 61 | 0.280 |
Why?
|
| Motor Skills Disorders | 2 | 2007 | 14 | 0.270 |
Why?
|
| Brain | 9 | 2012 | 2391 | 0.260 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2023 | 54 | 0.260 |
Why?
|
| Infant, Extremely Premature | 4 | 2019 | 43 | 0.250 |
Why?
|
| Hypoxia, Brain | 2 | 2007 | 43 | 0.240 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2012 | 297 | 0.220 |
Why?
|
| Infant, Premature, Diseases | 4 | 2021 | 80 | 0.220 |
Why?
|
| Neonatology | 1 | 2024 | 18 | 0.220 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2014 | 30 | 0.200 |
Why?
|
| Animals | 24 | 2021 | 28148 | 0.200 |
Why?
|
| Enzyme Inhibitors | 3 | 2011 | 641 | 0.190 |
Why?
|
| Nitric Oxide | 4 | 2012 | 281 | 0.190 |
Why?
|
| Conservative Treatment | 2 | 2019 | 25 | 0.180 |
Why?
|
| Phospholipids | 1 | 2021 | 108 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2005 | 414 | 0.170 |
Why?
|
| Female | 27 | 2023 | 48696 | 0.170 |
Why?
|
| Fetal Diseases | 2 | 2015 | 75 | 0.160 |
Why?
|
| Neuroprotective Agents | 2 | 2012 | 98 | 0.150 |
Why?
|
| Muscle, Skeletal | 3 | 2014 | 474 | 0.150 |
Why?
|
| Brain Injuries | 2 | 2012 | 164 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 624 | 0.150 |
Why?
|
| Biological Products | 1 | 2021 | 178 | 0.150 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 159 | 0.150 |
Why?
|
| Vasoconstriction | 1 | 2019 | 88 | 0.140 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2018 | 38 | 0.140 |
Why?
|
| Motor Activity | 2 | 2015 | 323 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 829 | 0.130 |
Why?
|
| Oligodendroglia | 2 | 2010 | 77 | 0.130 |
Why?
|
| Counseling | 1 | 2019 | 168 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 423 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 185 | 0.130 |
Why?
|
| Caregivers | 1 | 2019 | 180 | 0.130 |
Why?
|
| Pregnancy Outcome | 2 | 2012 | 268 | 0.130 |
Why?
|
| Parents | 1 | 2019 | 292 | 0.120 |
Why?
|
| Research Design | 1 | 2019 | 616 | 0.110 |
Why?
|
| Patient Selection | 1 | 2019 | 690 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 836 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 920 | 0.110 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2015 | 14 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2015 | 32 | 0.110 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2014 | 3 | 0.110 |
Why?
|
| Humans | 22 | 2024 | 93501 | 0.100 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2015 | 91 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 590 | 0.100 |
Why?
|
| Phenylketonurias | 1 | 2013 | 16 | 0.100 |
Why?
|
| Serotonin | 1 | 2015 | 209 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2015 | 172 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2015 | 241 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2014 | 141 | 0.100 |
Why?
|
| White Matter | 1 | 2014 | 96 | 0.100 |
Why?
|
| Olfactory Perception | 1 | 2012 | 23 | 0.090 |
Why?
|
| Muscle Hypotonia | 1 | 2012 | 48 | 0.090 |
Why?
|
| Indazoles | 1 | 2011 | 58 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2012 | 579 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 148 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 192 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2014 | 3476 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2021 | 159 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 578 | 0.080 |
Why?
|
| Behavior, Animal | 3 | 2015 | 390 | 0.080 |
Why?
|
| Pterins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Dystonia | 1 | 2009 | 31 | 0.080 |
Why?
|
| Fetal Development | 1 | 2009 | 35 | 0.080 |
Why?
|
| Joints | 1 | 2009 | 32 | 0.070 |
Why?
|
| Weight-Bearing | 1 | 2009 | 71 | 0.070 |
Why?
|
| Postural Balance | 1 | 2009 | 53 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1049 | 0.070 |
Why?
|
| Swimming | 1 | 2009 | 64 | 0.070 |
Why?
|
| Range of Motion, Articular | 1 | 2009 | 178 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 2 | 2019 | 61 | 0.070 |
Why?
|
| Extremities | 1 | 2009 | 176 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 488 | 0.070 |
Why?
|
| Male | 9 | 2023 | 44552 | 0.070 |
Why?
|
| Action Potentials | 2 | 2014 | 581 | 0.060 |
Why?
|
| Stem Cells | 1 | 2010 | 386 | 0.060 |
Why?
|
| Movement | 1 | 2009 | 304 | 0.060 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2007 | 19 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2020 | 4559 | 0.060 |
Why?
|
| Sensation Disorders | 1 | 2006 | 31 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2009 | 408 | 0.060 |
Why?
|
| Abruptio Placentae | 1 | 2005 | 13 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 9097 | 0.060 |
Why?
|
| Smell | 1 | 2006 | 121 | 0.060 |
Why?
|
| Neurons | 1 | 2013 | 1581 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 204 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2005 | 57 | 0.060 |
Why?
|
| Time Factors | 4 | 2020 | 5410 | 0.060 |
Why?
|
| Age Factors | 3 | 2014 | 1906 | 0.050 |
Why?
|
| Mitochondria | 3 | 2013 | 612 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2014 | 76 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2024 | 285 | 0.050 |
Why?
|
| Respiratory Sounds | 1 | 2023 | 39 | 0.050 |
Why?
|
| Motor Skills | 1 | 2004 | 77 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2023 | 57 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2013 | 32 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2023 | 137 | 0.050 |
Why?
|
| Dyspnea | 1 | 2023 | 86 | 0.050 |
Why?
|
| Catheterization | 1 | 2023 | 218 | 0.050 |
Why?
|
| Basal Ganglia | 2 | 2013 | 46 | 0.040 |
Why?
|
| Motor Cortex | 1 | 2004 | 209 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2023 | 283 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2021 | 83 | 0.040 |
Why?
|
| Infant | 2 | 2023 | 3220 | 0.040 |
Why?
|
| Aging | 1 | 2005 | 727 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 1713 | 0.040 |
Why?
|
| Olfactory Bulb | 2 | 2012 | 41 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 48 | 0.040 |
Why?
|
| Intensive Care, Neonatal | 1 | 2019 | 14 | 0.040 |
Why?
|
| San Francisco | 1 | 2019 | 25 | 0.040 |
Why?
|
| United States | 2 | 2024 | 7619 | 0.040 |
Why?
|
| Ductus Arteriosus | 1 | 2019 | 28 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 63 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 181 | 0.040 |
Why?
|
| Models, Animal | 2 | 2012 | 282 | 0.030 |
Why?
|
| Risk | 1 | 2019 | 657 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 657 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2802 | 0.030 |
Why?
|
| Birth Weight | 1 | 1997 | 150 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 3828 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2023 | 3829 | 0.030 |
Why?
|
| Mothers | 1 | 1997 | 142 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1948 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2015 | 49 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1917 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2014 | 71 | 0.030 |
Why?
|
| Electron Microscope Tomography | 1 | 2014 | 21 | 0.030 |
Why?
|
| Leukoencephalopathies | 1 | 2014 | 14 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 137 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 83 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2014 | 344 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 279 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2014 | 194 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 220 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 2012 | 16 | 0.020 |
Why?
|
| Valinomycin | 1 | 2012 | 8 | 0.020 |
Why?
|
| Olfactory Mucosa | 1 | 2012 | 33 | 0.020 |
Why?
|
| Thalamus | 1 | 2013 | 132 | 0.020 |
Why?
|
| Ionophores | 1 | 2012 | 14 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2012 | 17 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2012 | 19 | 0.020 |
Why?
|
| O Antigens | 1 | 2012 | 12 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2012 | 26 | 0.020 |
Why?
|
| Chromans | 1 | 2012 | 28 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2012 | 40 | 0.020 |
Why?
|
| Xenon | 1 | 2012 | 7 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 1799 | 0.020 |
Why?
|
| Superoxides | 1 | 2012 | 75 | 0.020 |
Why?
|
| Melatonin | 1 | 2012 | 46 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 68 | 0.020 |
Why?
|
| Allopurinol | 1 | 2012 | 77 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 217 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2012 | 90 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 179 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2012 | 112 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 1004 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 89 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 176 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 231 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 2910 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 712 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 162 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 77 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2009 | 120 | 0.020 |
Why?
|
| Citrulline | 1 | 2009 | 10 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 123 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 543 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 797 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2012 | 569 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 141 | 0.020 |
Why?
|
| Drug Design | 1 | 2009 | 133 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1300 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 321 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1910 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 422 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 520 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 12263 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 57 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 14 | 0.020 |
Why?
|
| Manganese | 1 | 2006 | 56 | 0.020 |
Why?
|
| Anisotropy | 1 | 2006 | 63 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 66 | 0.010 |
Why?
|
| Odorants | 1 | 2006 | 72 | 0.010 |
Why?
|
| Risk Factors | 2 | 2012 | 5898 | 0.010 |
Why?
|
| Axons | 1 | 2006 | 179 | 0.010 |
Why?
|
| Epithelium | 1 | 2006 | 316 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 884 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 896 | 0.010 |
Why?
|
| ROC Curve | 1 | 2007 | 775 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1133 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1161 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 27918 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3500 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 675 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 1261 | 0.010 |
Why?
|
| West Indies | 1 | 1997 | 4 | 0.010 |
Why?
|
| England | 1 | 1997 | 38 | 0.010 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 1997 | 50 | 0.010 |
Why?
|
| Africa | 1 | 1997 | 109 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1997 | 80 | 0.010 |
Why?
|
| Social Support | 1 | 1997 | 233 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1997 | 624 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1997 | 1847 | 0.010 |
Why?
|